2:09 PM · 2 November 2021

Pfizer stock jumped 4% in pre-market as total COVID vaccine sales soar

Pfizer (PFE.US) stock price rose sharply before the opening bell after the pharmaceutical company posted upbeat quarterly results. In the third quarter Pfizer earned $1.34 per share, well above analysts' estimates of $1.09 per share. Revenue also topped market expectations. Group sales for the third-quarter sales were 130% higher than a year earlier at $24.1 billion, while Wall Street expected $22.58 billion in revenue helped by soaring international sales of its Covid-19 vaccine. 

The company also issued an improved full-year guidance on strong demand for both its Covid-19 vaccine and non-Covid treatments. The drugmaker now expects 2021 adjusted earnings of $4.13 to $4.18 per share on revenue ranging from $81 billion to $82 billion. Meanwhile for 2021, analysts expect earnings of $4.04 per share on $78.77 billion in revenue. Company now expects to book about $36 billion in sales from the vaccine this year.

Pfizer (PFE.US) stock rose 4% in pre-market and is currently testing 38.2% Fibonacci retracement of the last downward wave. Source: xStation5

5 June 2026, 3:45 PM

NFP: A turning point for the dollar and the start of a stock market correction?

5 June 2026, 2:49 PM

US Open: Wall Street slides amid semiconductor stocks sell-off 📌Intel down 6%

5 June 2026, 12:44 PM

Market Wrap: SAP bucks tech sell-off, SpaceX blocked from S&P 500 entry (05.06.2026)

5 June 2026, 12:10 PM

Lululemon Athletica slumps 14% after earnings amid weak North America sales 📉

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits